臺灣博碩士論文加值系統

唐氏症 ( Down’s syndrome ) 是細胞遺傳學最常發生的染色體變異(chromosomal aberration)。主要變異的形式為第21對染色體多出一條；即為 trisomy 21。目前對於此疾病無論是臨床症狀、細胞遺傳學或分子遺傳學已有很多相關的研究，但是對於染色體為何在生殖細胞有絲分裂 ( mitosis) 或減數分裂 ( meiosis) 階段容易形成trisomy的原因迄今仍未明瞭。最近有研究報告指出氧化性壓力 (oxidative stress) 可能與trisomy的形成有關，並進而在其細胞內產生氧化壓力。而粒線體是細胞內產生自由基的主要胞器，我們推論在唐氏症患者的細胞內其粒線體功能缺陷，可能與唐氏症病患的病程有關。本研究我們針對唐氏症病患羊水細胞內粒線體DNA (mtDNA) 的拷貝數目 (copy number) 、粒線體DNA斷損突變 (mtDNA deletion) 進行研究分析，並進而探討其與氧化性傷害的相關性。我們以PCR方法檢測粒線體DNA發生的斷損突變，發現於病患羊水細胞內常有5335 bp deletion。並以real-time PCR測定粒線體DNA拷貝數。以流式細胞儀測定羊水細胞脂質過氧化物 (lipid peroxide) 含量，並以螢光染劑C11-BODIPY lipid probes檢測過氧化物對唐氏症病患羊水細胞傷害的程度。由實驗結果顯示唐氏症病患羊水細胞粒線體DNA拷貝數較正常人羊水細胞粒線體DNA拷貝數減少至0.9倍，此外也發現以primer pair L8251-H13845檢測細胞內有5335 bp粒線體DNA斷損突變，經DNA序列分析其斷點為核苷酸序列8273-13607，在DNA序列8263-8272及13598-13607具有”CCTATAGCAC”的10個nucleotide長的direct repeat。粒線體的數目減少與粒線體DNA斷損突變是否影響粒線體功能進而促成trisomy cell bio-aging的形成需進一步探討。病患的羊水細胞中氧化傷害的指標物質脂質過氧化物（lipid peroxides）及8-OHdG則較正常人羊水細胞高。我們推測唐氏症病患羊水細胞有較高的oxidative stress導致mtDNA 受損及copy number減少。

Down’s syndrome is the most common disease of chromosomal aberration on cytogenetics. The major form of chromosomal aberration is trisomy 21, an extra chromosome of chromosome 21. There are many studies in Down’s syndrome including clinical pathology, cytogenetics and molecular genetics. It is distinct why the germ cells are susceptible to trisomy formation at meiosis or mitosis stage. Recently, some researches reported that oxidative stress might play some roles in the formation of trisomy. Mitochondria are the major organelles that produce reactive oxygen species. In this study, we hypothesized the mitochondrial dysfunction might be contributed to the pathogenesis of Down’s syndrome. We investigated on mitochondria DNA (mtDNA) copy number, mtDNA deletion and oxidative damages in amniotic cells of Down’s syndrome patient. Decreased copy numbers of mtDNA were found in the patients of Down’s syndrome. Moreover, a novel 5335 bp mtDNA deletion was identified in amniotic cells from Down’s syndrome patient. Analysis of nucleotide sequences flanking the breakpoints of this deletion revealed a 10 nucleotides direct repeat “CCTATAGCAC” flanking the junction site of the 5335 bp deletion at nucleotide position 8263-8272 and 13598-13607. Increased ROS generation and oxidative damages were revealed in Down’s amniotic cells. Taken these data together, we suggested that the dysfunctional mitochondria might play a role in the pathogenesis of Down’s syndrome.

論文摘要 I
英文摘要 III
目 錄 V
圖表目次 VI
縮 寫 表 VIII
壹 緒論
一. Down’s syndrome 1
二. 粒線體的構造與功能 4
三. 粒線體基因 4
四. 粒線體基因突變與疾病 5
貳 實驗方法與材料 8
參 結果 17
肆 討論 21
參考文獻 42

參考文獻
Abraham, C.R., Selkoe, D.J., Potter, H. (1988) Immunochemcal identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer’s disease. Cell, 52:487-501.
Anderson, S., Bankier, A.T., Barrel, B.G., De Bruijn, M.H.L., Coulson , A.R., Drouin, J., Eperon, I.C., Sanger, F., Schreier, P.H., Smith, A.J.H., Staden, R. and Young, I.G. (1981) Sequence and organization of the human mitochondrial genome. Nature, 290: 457-465.
Anneren, K.G., and Epstein, C.J. (1987) Lipid peroxidation and superoxide dismutase-1and glutathione peroxidase activities in trisomy 16 fetal mice and human trisomy 21 fibroblasts. Pediatr Res, 21:88—92.
Arbuzova, S. (1998) Why it is necessary to study the role of the mitochondrial genome in trisomy 21 pathogenesis? Down’s Syndrome Research and Practice, 5：26-29.
Attardi, G., Montoya, J. (1983) Analysis of human mitochondrial RNA. Methods Enzymol, 97: 435-469
Attardi, G., Chomyn, A., Montoya, J., and Ojala, D. (1982) Identification and mapping of human mitochondrial genes. Cytogenet Cell Genet, 32: 85-98.
Barritt, J.A., Kokot, M., Cohen, J., Steuerwald, N., and Brenner, C.A. (2002) Quantification of human ooplasmic mitochondria. Reprod Biomed Online, 4:243-247.
Beckman, K. B., and B. N. Ames. (1998) The free radical theory of aging
matures. Physiol Rev, 78:547—581.
Bhat, H.K. (2002) Depletion of mitochondrial DNA and enzyme in estrogen-induced hamster kidney tumors: a rodent model of hormonal carcinogenesis. J Biochem Mol Toxicol, 16:1-9.
Bogenhagen, D.F. (1999) Repair of mtDNA in vertebrates. Am J Hum Genet, 64: 1276-1281.
Brooksbank, B.W., and Balazs, R. (1984) Superoxide-dismutase, glutathione peroxidase and lipoperoxidation in Down’s syndrome fetal brain. Brain Res, 318:37—44.
Busciglio Jorge and Yanker Bruce A. (1995) Apoptosis and increase generation of reactive oxygen species in Down’s syndrome neurons in vitro. Nature, 378:776-779.
Cai, J., Wu, M., Nelson, K. C., Sternberg, P. Jr., and Jones, D. P. (1999) Invest Ophthalmol Visual Sci, 40, 959-966.
Choi, Y. S., Kim, S., Pak, Y. K.（2001）Mitochondrial transcription factor A（mtTFA）and diabetes. Diabetes Res Clin Pract,54:Suppl 2: 3-9
Clayton, D.A. (1984) Transcription of the maintain mitochondrial genome. Annu Rev Biochem, 53:573-594.
Harman D. (2002) Alzheimer’s Disease: Role of aging in pathogenesis. Ann N Y Acad Sci, 959:348-395.
Green, D.R. (1998) Mitochondria and Apoptosis. Science, 281 : 1309-1312.
Green, D.R. (2000) Apoptotic pathways: paper wraps stone blunts scissors. Cell, 102, 1-4.
Ide, T., Tsutsui, H., Hayashidani, S., Kang, D., Suematsu, N., Nakamura, K., Utsumi, H., Hamasaki, N., and Takeshita, A. (2001) Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res, 88:529-35.
Knerr, I., Metzler, M., Niemeyer, C. M., Holter, W., et al. (2003) Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA. J Pediatr Hematol Oncol, 25:948-951.
Kroemer, G., Zamzami, N., and Susin, S. A. (1997). Mitochondrial control of apoptosis. Immunol Today, 18:44-51
Lacbawan, F., Tifft, C.J., Luban, NL., Schmandt, SM., Guerrera, M., Weinstein, S., Pennybacker, M., Wong, LJ. (2000) Clinical heterogenecity in mitochondrial DNA deletion disorders: A diagnostic challenge of Pearsons’ syndrome. Am J Med Gen, 95:266—268.
Lee, H.C., Pang, C.Y., Hsu, H.S., Wei, Y.H. (1996) Differential accumulations of 4,977 bp deletion in mitochondrial DNA of various tissues in human aging. Biochim Biophys Acta, 1226:37-43.
Lee, S.H., Lee, S., Jun, H.S., Jeong, H.J., Cha, W.T., Cho, Y.S., Kim, J.H., Ku, S.Y. and Cha, K.Y. (2003) Expression of the mitochondrial ATPase 6 gene and Tfam in Down syndrome. Mol Cell, 15:181-185.
Lightowlers, R.N., Chinnery, P.F., Turnbull, DM.,and Howell, N. (1997) Mammalian mitochondrial genetics : heredity, heteroplasmy and disease. Trend Genet, 13: 450-455.
Lin, P.H., Lee, S.H., Su, C.P., Wei, Y.H. (2003) Oxidative damage to mitochondrial DNA in atrial muscle of patients with artial fibrillation. Free Radic Biol Med, 35:1310-1318
Liu, C.S., Tsai, C.S., Kuo, C.L., Chen, H.W., Lii, C.K., Ma, Y.S., Wei, Y.H. (2003) Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. Free Radic Res, 37:1307-1317.
Lott, I,T., Head, E. Down syndrome and Alzheimer’s desease: a link between development and aging. Mental Retardation & Developmental Disabilities Research Reviews. 7: 172-8
McShane, MA., Hammans, S.R., Sweeney, M.G., Holt, I.J., Beattie, T.J., Brett, E.M. and Harding, A.E. (1991) Pearson syndrome and mitohcondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet , 48: 39-42.
Piconi, L., Quagliaro, L., Ceriello, A. (2003) Oxidative stress in diabetes. Clin Chem Lab Med, 41:1144-1149.
Richter, C. (1988) Do mitochondrial DNA fragments promote cancer and aging? FEBS Lett, 241: 1-5.
Saphier, C. J. . and Yeh, J. (1998) Altered apoptosis levels in hearts of human fetuses with Down syndrome. American Journal of Obstetrics and Gynecology, 179:962-965.
Suematsu, N., Tsutsui, H., Wen, J., Kang, D., Ikeuchi,M., Ide,T., Hayashidani, S., Shiomi, T., Kubota, T., Hamasaki, N., and Takeshita, A. (2003) Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation , 107:1418-1423.
Suliman, H.B., Carraway, M.S., and Piantadosi, C.A. (2003) Postlipopolysaccharide oxidative damage of mitochondrial DNA. Am J Respir Crit Care Med, 167:570-579.
Susin, S.A., Lorenzo, H.K., Zamzami, N., Marzo, I,. Snow B.E., Brothers, G.M., Mangion, J., Jacotot, E., Costantini, P., Loeffler, M., Larochette, N., Goodlett, D.R., Aebersold, R., Siderovski, D.P., Penninger, J.M., Kroemer, G. (1999) Molecular characterization of mitochondrial apoptosis-inducing factor. Nature, 397: 441-446.
Taanman, J.W. (1999) The mitochondrial genome: structure, transcription, translation and replication. Biochim Biophys Acta , 1410: 103-123.
Verhagen, A.M., Ekert, P.G., Pakusch, M., Silke, J., Connolly, L.M., Reid, G.E., Moritz, R.L., Simpson, R.J., Vaux, D.L. (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell , 102: 43-53.
Vander Heiden, M.G., Chandel, N.S., Li, X.X., Schumacker, P.T., Colombini, M., Thompson, C.B. （2000）Outer mitochondrial membrane permeability can regulate coupled respiration and cell survival. Proc Natl Acad Sci USA , 97: 4666-4671.
Vittecoq, D., Jardel, C., Barthelemy, C., Escaut, L., Cheminot, N., Chapin, S., Sternberg, D., Maisonobe, T., and Lombes, A. (2002) Mitochondrial damage associated with long-term anti-retroviral treatment: associated alteration or causal disorder?
J Acquir Immune Defic Syndr, 31:299-308.
Wallace, D.C. (1982) Structure and evolution of organelle genomes. Microbiol Rev, 46: 208-240.
Wallace, D.C. (1993) Mitochondrial diseases: genotype versus phenotype. TIG, 9: 128-133.
Wisniewki, K.E., Wisniewkwi, H.M., Wen G,Y,. Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann Neurol 17:457-76
Wong, S.H., Knight, J.A. Hopfer, S.M., Zaharia. O., Leach, C.N. and Sunderman, F.W. (1987) Lipoperoxides in plasma as measures by lipid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem, 33, 214-20.
Yakes, F.M. and Van Houten, B. (1997) Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA , 94: 514-519.
Yin, P.H., Lee, H.C., Chau, G.Y., Wu, Y.T., Li, S.H., Lui, W.Y., Wei, Y.H., Liu, T.Y. and Chi, C.W. (2004) Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br J Cancer.
Zeviani, M., Tiranti, V., and Piantadosi, C. (1998) Mitochondrial disorders. Medicine, 77: 59-72.
Zeviani, M., Moraes, C.T., DiMauro, S., Nakase, H., Bonilla, E., Schon, E.A., and Rowland, L.P. (1988) Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology, 38: 1339-1346.
Zipursky, A., Peeters, M., Poon, A. (1987) Megakaryoblastic leukemia and Down syndrome--A review. Pediatric Hematology & Oncology. 4:211-230